Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY36.10 CNY
Change Today +0.52 / 1.46%
Volume 69.1M
600518 On Other Exchanges
As of 3:05 AM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

kangmei pharmaceutical co-a (600518) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/10/15 - CNY40.80
52 Week Low
07/18/14 - CNY13.80
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for KANGMEI PHARMACEUTICAL CO-A (600518)

Related News

No related news articles were found.

kangmei pharmaceutical co-a (600518) Related Businessweek News

No Related Businessweek News Found

kangmei pharmaceutical co-a (600518) Details

Kangmei Pharmaceutical Co., Ltd. manufactures and sells pharmaceuticals and medical devices primarily in China. The company's principal products include Chinese medicines, such as American ginseng, notoginseng powder, salvia powder, radix codonopsis pilosulae, maltiflower knotweed, angelica, lonicera flower, and others. Its products also comprise chemical drugs consisting of clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, paracetamol and pseudoephedrine hydrochloride tablets, and others. In addition, the company is involved in the wholesale and retail of other medical materials, such as bird's nest, ganoderma, sea horse, isinglass, forest frog, and others. Kangmei Pharmaceutical Co., Ltd. was founded in 1997 and is headquartered in Puning, China.

Founded in 1997

kangmei pharmaceutical co-a (600518) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

kangmei pharmaceutical co-a (600518) Key Developments

Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the Year 2014

Kangmei Pharmaceutical Co., Ltd. reported earnings results for the year 2014. For the year, the company reported basic earnings per share of CNY 1.040 and weighted average return on net assets of 17.74%.

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Apr 08, 2015

Kangmei Pharmaceutical Co., Ltd., Board Meeting, Apr 08, 2015. Agenda: To discuss and approve issues including the full text of annual report of 2014 and its abstract; to consider scheme of profit distribution and capitalization from Capital Public Reserve for 2014; and to consider the proposal of scheme of dividend distribution of preferred shares for 2014.

Kangmei Pharmaceutical Co., Ltd. Approves Proposal to Invest RMB 1 Billion in Constructing China - Asean Kangmei Yulin Herbs Industry Park Project

Kangmei Pharmaceutical Co., Ltd. held the first special shareholders' meeting of 2015 on January 30, 2015, which discussed and approved the proposal of planning to invest RMB 1 billion in constructing China - ASEAN Kangmei Yulin Herbs Industry Park Project and the proposal of changing business scope.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600518:CH CNY36.10 CNY +0.52

600518 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600518.
View Industry Companies

Industry Analysis


Industry Average

Valuation 600518 Industry Range
Price/Earnings 34.8x
Price/Sales 5.0x
Price/Book 5.8x
Price/Cash Flow 34.8x
TEV/Sales 3.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KANGMEI PHARMACEUTICAL CO-A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at